ASMB

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Assembly Biosciences Inc

NASDAQ | ASMB

37.01

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 17, 2025)

$580.65M

Market Cap

-

P/E Ratio

-4.6

EPS

$37.62

52 Week High

$7.75

52 Week Low

HEALTHCARE

Sector

ASMB Chart

Recent Chart
Price Action

ASMB Technicals

Tags:

ASMB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $29M
Total Revenue $29M
Cost Of Revenue $129K
Costof Goods And Services Sold $129K
Operating Income -$45M
Selling General And Administrative $18M
Research And Development $56M
Operating Expenses $74M
Investment Income Net -
Net Interest Income $5.6M
Interest Income $5.6M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $129K
Income Before Tax -$40M
Income Tax Expense $330K
Interest And Debt Expense -
Net Income From Continuing Operations -$40M
Comprehensive Income Net Of Tax -
Ebit -$45M
Ebitda -$45M
Net Income -$40M

Revenue & Profitability

Earnings Performance

ASMB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $119M
Total Current Assets $116M
Cash And Cash Equivalents At Carrying Value $38M
Cash And Short Term Investments $38M
Inventory -
Current Net Receivables $400K
Total Non Current Assets $3.7M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $74M
Other Current Assets $3M
Other Non Current Assets -
Total Liabilities $86M
Total Current Liabilities $48M
Current Accounts Payable $585K
Deferred Revenue -
Current Debt -
Short Term Debt $461K
Total Non Current Liabilities $38M
Capital Lease Obligations $3.1M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.1M
Other Current Liabilities $9.1M
Other Non Current Liabilities -
Total Shareholder Equity $33M
Treasury Stock -
Retained Earnings -$826M
Common Stock $7K
Common Stock Shares Outstanding $6M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$51M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $129K
Capital Expenditures $28K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $40M
Cashflow From Financing $29M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$40M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $29M
Total Revenue $29M
Cost Of Revenue $129K
Costof Goods And Services Sold $129K
Operating Income -$45M
Selling General And Administrative $18M
Research And Development $56M
Operating Expenses $74M
Investment Income Net -
Net Interest Income $5.6M
Interest Income $5.6M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $129K
Income Before Tax -$40M
Income Tax Expense $330K
Interest And Debt Expense -
Net Income From Continuing Operations -$40M
Comprehensive Income Net Of Tax -
Ebit -$45M
Ebitda -$45M
Net Income -$40M

ASMB News

ASMB Profile

Assembly Biosciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Assembly Biosciences, Inc. (ASMB) is a clinical-stage biotechnology company based in South San Francisco, California, dedicated to developing innovative therapies targeting viral infections and liver diseases, principally hepatitis B. The company’s proprietary core inhibitor technology underpins a robust pipeline of drug candidates designed to meet significant unmet medical needs in chronic infection treatment. With a strategic focus on transforming current treatment paradigms, Assembly Biosciences represents a compelling investment opportunity for institutional investors looking to capitalize on breakthroughs in the biopharmaceutical industry.

WTO
+28.45%
$0.03
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
AMIX
+46.56%
$1.06
KXIN
+2.47%
$0.31
APLT
+67.79%
$0.36
VHAI
+33.33%
$0.00
CHR
-6.36%
$0.04
ONDS
-13.71%
$6.19
NVDA
-2.57%
$185.27
ASST
-8.54%
$0.98
GLMD
+9.61%
$1.14
TSLA
+0.45%
$406.19
AXDX
-61.36%
$0.03
DVLT
+1.91%
$1.86
GNS
+6.38%
$0.91
QUBT
+7.88%
$11.43
PLUG
-7.18%
$2.08
SOFI
-3.43%
$26.86
PFE
+0.65%
$25.22
DNN
-4.84%
$2.35
ADAP
-15.14%
$0.05
DFLI
-2.62%
$0.78
INTC
-2.81%
$34.51
BYND
-5.55%
$1.02
AMZN
-1.62%
$230.86
BURU
-13.22%
$0.21
F
-2.31%
$12.88
ACHR
-7.61%
$7.28
MARA
-6.71%
$11.18
NIO
-0.97%
$6.09
RMBL
+60.50%
$3.21
GOOGL
+2.76%
$284.04
RIVN
-2.02%
$14.80
ETHD
+7.15%
$5.60
LNW
-3.71%
$86.22
BITF
-1.22%
$2.54
ADD
-25.47%
$0.05
PLTR
-3.12%
$168.56
MSPR
+10.72%
$0.49
GPUS
-18.49%
$0.22
BMNR
-10.04%
$30.94
SRM
+53.27%
$10.30
RIG
+2.73%
$4.11
TLRY
-3.74%
$1.03
ASBP
-13.35%
$0.09
SNAP
-4.14%
$8.21
RGTI
-3.17%
$24.67
WULF
-1.94%
$10.77
WLGS
-5.57%
$0.04
PLTD
+3.50%
$7.07
HPE
-8.45%
$20.90
MTSR
-0.35%
$70.50
AMD
-3.10%
$239.14
XPEV
-9.00%
$22.75
GRAB
-1.58%
$5.32
GOOG
+2.97%
$285.21
AAL
-2.39%
$12.45
CAN
-5.80%
$0.84
CIFR
-2.54%
$13.99
IONZ
-0.19%
$5.18
AAPL
-1.89%
$267.26
HOOD
-7.23%
$113.63
TWOH
0.00%
$0.00
AFMD
-34.94%
$0.18
BTG
-3.86%
$3.94
IREN
+1.29%
$46.97
AMC
-6.40%
$2.13
BBD
-1.36%
$3.62
MU
-2.11%
$241.60
NOK
-0.37%
$6.70
T
-0.13%
$25.55
QBTS
-4.57%
$22.53
HIMS
-7.59%
$34.17
IVVD
+20.14%
$2.82
SOUN
-6.12%
$11.42
SMCI
-6.37%
$34.09
KVUE
+2.13%
$17.01
CLSK
-4.09%
$10.51
GRYP
-10.38%
$1.38
BTE
-3.37%
$3.05
MODV
-25.22%
$0.43
CRCA
-15.14%
$4.09
EOSE
-6.34%
$12.92
RXRX
-2.29%
$4.04
CRWV
-4.82%
$73.63
CGC
-3.15%
$1.03
IONQ
-0.48%
$46.95
BTBT
-5.33%
$2.28
PLTZ
+6.25%
$7.31
WBD
-2.14%
$22.53
JOBY
-5.58%
$13.60
CRCL
-7.87%
$75.44
APLD
-1.96%
$23.18
NBIS
+3.30%
$86.30
SMR
-7.97%
$20.65
NFLX
-90.12%
$109.88
BAC
-1.50%
$51.81
LAES
-9.27%
$4.07
PSNY
-1.18%
$0.51
WTO
+28.45%
$0.03
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
AMIX
+46.56%
$1.06
KXIN
+2.47%
$0.31
APLT
+67.79%
$0.36
VHAI
+33.33%
$0.00
CHR
-6.36%
$0.04
ONDS
-13.71%
$6.19
NVDA
-2.57%
$185.27
ASST
-8.54%
$0.98
GLMD
+9.61%
$1.14
TSLA
+0.45%
$406.19
AXDX
-61.36%
$0.03
DVLT
+1.91%
$1.86
GNS
+6.38%
$0.91
QUBT
+7.88%
$11.43
PLUG
-7.18%
$2.08
SOFI
-3.43%
$26.86
PFE
+0.65%
$25.22
DNN
-4.84%
$2.35
ADAP
-15.14%
$0.05
DFLI
-2.62%
$0.78
INTC
-2.81%
$34.51
BYND
-5.55%
$1.02
AMZN
-1.62%
$230.86
BURU
-13.22%
$0.21
F
-2.31%
$12.88
ACHR
-7.61%
$7.28
MARA
-6.71%
$11.18
NIO
-0.97%
$6.09
RMBL
+60.50%
$3.21
GOOGL
+2.76%
$284.04
RIVN
-2.02%
$14.80
ETHD
+7.15%
$5.60
LNW
-3.71%
$86.22
BITF
-1.22%
$2.54
ADD
-25.47%
$0.05
PLTR
-3.12%
$168.56
MSPR
+10.72%
$0.49
GPUS
-18.49%
$0.22
BMNR
-10.04%
$30.94
SRM
+53.27%
$10.30
RIG
+2.73%
$4.11
TLRY
-3.74%
$1.03
ASBP
-13.35%
$0.09
SNAP
-4.14%
$8.21
RGTI
-3.17%
$24.67
WULF
-1.94%
$10.77
WLGS
-5.57%
$0.04
PLTD
+3.50%
$7.07
HPE
-8.45%
$20.90
MTSR
-0.35%
$70.50
AMD
-3.10%
$239.14
XPEV
-9.00%
$22.75
GRAB
-1.58%
$5.32
GOOG
+2.97%
$285.21
AAL
-2.39%
$12.45
CAN
-5.80%
$0.84
CIFR
-2.54%
$13.99
IONZ
-0.19%
$5.18
AAPL
-1.89%
$267.26
HOOD
-7.23%
$113.63
TWOH
0.00%
$0.00
AFMD
-34.94%
$0.18
BTG
-3.86%
$3.94
IREN
+1.29%
$46.97
AMC
-6.40%
$2.13
BBD
-1.36%
$3.62
MU
-2.11%
$241.60
NOK
-0.37%
$6.70
T
-0.13%
$25.55
QBTS
-4.57%
$22.53
HIMS
-7.59%
$34.17
IVVD
+20.14%
$2.82
SOUN
-6.12%
$11.42
SMCI
-6.37%
$34.09
KVUE
+2.13%
$17.01
CLSK
-4.09%
$10.51
GRYP
-10.38%
$1.38
BTE
-3.37%
$3.05
MODV
-25.22%
$0.43
CRCA
-15.14%
$4.09
EOSE
-6.34%
$12.92
RXRX
-2.29%
$4.04
CRWV
-4.82%
$73.63
CGC
-3.15%
$1.03
IONQ
-0.48%
$46.95
BTBT
-5.33%
$2.28
PLTZ
+6.25%
$7.31
WBD
-2.14%
$22.53
JOBY
-5.58%
$13.60
CRCL
-7.87%
$75.44
APLD
-1.96%
$23.18
NBIS
+3.30%
$86.30
SMR
-7.97%
$20.65
NFLX
-90.12%
$109.88
BAC
-1.50%
$51.81
LAES
-9.27%
$4.07
PSNY
-1.18%
$0.51
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.